Skip to main content

Suven Life Sciences

Healthcare NSE:SUVEN

126.65INR
-7.38 ( -5.51%)

Last update at March 23, 2026, midnight

Day Range

124.76134.00
LowHigh

52 Week Range

102.50 299.99
LowHigh

Fundamentals

  • Previous Close 134.03
  • Market Cap 37344.44M
  • Volume406,272
  • P/E Ratio -
  • EBITDA -2133.43M
  • Revenue TTM 58.63M
  • Revenue Per Share TTM 0.27
  • Gross Profit TTM 51.12M
  • Diluted EPS TTM -9.61

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED CIPLA ₹ 1515.70 4/11/25 4/11/25 Same Day Short Term Healthcare -0.79%
CLOSED CIPLA ₹ 1499.85 18/03/25 18/03/25 Same Day Short Term Healthcare 0.72%
CLOSED CIPLA ₹ 1452.00 11/03/25 11/03/25 Same Day Short Term Healthcare 0.69%
CLOSED CIPLA ₹ 1457.00 14/02/25 14/02/25 Same Day Short Term Healthcare 0.24%

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax -1607.45M -1060.79M -1182.68M -1219.95M -774.74M
Net income -1607.45M -1050.76M -1182.68M -1219.95M -721.51M
Total Revenue 66.56M 116.93M 135.39M 118.44M 134.78M
Gross Profit -276.34M 108.69M 129.74M 94.12M 133.75M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 1351.83M 2849.03M 3889.11M 1080.35M 1284.18M
Intangible assets 1.81M 1.99M 1.98M 2.25M 1.36M
Other current assets 138.18M 126.10M 84.23M 0.00M 0.00M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash 0.46M -220.87M 317.46M -40.75M -53.28M
Operating Cash -1484.69M -1154.69M -1031.48M -1275.37M -960.24M
Free Cash Flow -1857.45M -1154.69M -1060.43M -1473.09M -1023.28M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
SUVEN
Suven Life Sciences 		-7.38 -5.51% 126.65 37344.44 -
SUNPHARMA
Sun Pharmaceutical Industries Limited 		-18.70 -1.05% 1758.40 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		-86.50 -1.42% 6013.50 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		-56.30 -1.32% 4213.90 1362716.66 63.48
CIPLA
Cipla Limited 		-34.60 -2.75% 1221.80 1183505.97 21.74

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.